In our study, the hs-CRP level decreased by 72.59% after W-LHIT treatment, which confirmed that managing obesity can help reduce the risk of cardiovascular disease and comorbidities by inhibiting the inflammatory mechanism (25). This evidence concerns the gene CRP and obesity disorder.